Lutetium Lu 177 Vipivotide Tetraxetan

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 2 records

Lutetium Lu 177 Vipivotide Tetraxetan 2 markets · 2 records Forms
Filters
MarketUS 1GB 1

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 27 mCi per mL / per unit basis not statedinjectionPLUVICTO

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 12.5 mL per mL / per unit basis not statedinjectionPluvicto 7,400MBq/7.5-12.5ml solution for injection vials

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.